Treating Notch1-antagonist-resistant cancer (s) using Notch3 antagonists

Details for Australian Patent Application No. 2010300747 (hide)

Owner Genentech, Inc.

Inventors Siebel, Christian W.

Agent Griffith Hack

Pub. Number AU-A-2010300747

PCT Pub. Number WO2011/041336

Priority 61/247,298 30.09.09 US

Filing date 29 September 2010

Wipo publication date 7 April 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

26 April 2012 PCT application entered the National Phase

  PCT publication WO2011/041336 Priority application(s): WO2011/041336

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010300762-Impact sensing usable with fleet management system

2010300731-Method and apparatus for sealing containers